Benzamide, o-butoxy- → Ethyl 2-n-butoxybenzimidate fluoroborate

HRID 2082713

반응식

HRID 2082713 반응식
[F:1][B-:2]([F:5])([F:4])[F:3].[CH2:6]([O+](CC)CC)[CH3:7].[CH2:13]([O:17][C:18]1[CH:26]=[CH:25][CH:24]=[CH:23][C:19]=1[C:20]([NH2:22])=[O:21])[CH2:14][CH2:15][CH3:16]>C(Cl)Cl>[F:1][B-:2]([F:5])([F:4])[F:3].[CH2:13]([O:17][C:18]1[CH:26]=[CH:25][CH:24]=[CH:23][C:19]=1[C:20](=[NH:22])[O:21][CH2:6][CH3:7])[CH2:14][CH2:15][CH3:16]

참가 물질

4

실험 절차

A solution of triethyloxonium fluoroborate (32.4 g., 0.171 mole) in methylene chloride (75 ml.) was added to a stirred solution of 2-n-butoxybenzamide [J. Pharm. Pharmacol., 4, 872 (1952) ](33.0 g., 0.171 mole) in methylene chloride 8200 ml.) at 25°. The mixture was stirred at 25° for 20 hours. The solution was concentrated to about one fifth of the original volume and then diluted with diethyl ether. The precipitated solid was recrystallized from methylene chloride-diethyl ether to give ethyl 2-n-butoxybenzimidate fluoroborate (28.7 g.), m.p. 82°-88°. To a stirred, cooled (ice-water) suspension of the fluoroborate (28.7 g.) in ethanol (75 ml.) was added 8% ethanolic ammonia (150 ml.). The mixture was stirred at 25° for 20 hours. The ethanol was removed and the residue partitioned between ether and 5N sodium hydroxide (100 ml.). The ether layer was washed with brine, dried over sodium sulfate, and then concentrated. A solution of the residual oil in ether was treated with hydrogen chloride to precipitate the title compound (16.8 g.), m.p. 150°-155°.

후처리

  1. customat 25°
  2. concentrationThe solution was concentrated to about one fifth of the original volume
  3. additiondiluted with diethyl ether
  4. customThe precipitated solid was recrystallized from methylene chloride-diethyl ether

출처 및 근거

ORD 기록
ord-243540f203d1433fa0616da1dadcbd08
출처 데이터셋
uspto-grants-1978_04
특허 번호
US04082751

연결된 노트

불러오는 중…